Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02743039 · ClinicalTrials.gov registry record · NA
The Northwestern University Two-Generation Study of Parent and Child Human Capital Advancement
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 478
- Enrollment target
NCT02743039: Completed NA study, sponsored by Northwestern University.
NCT02743039 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 478 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02743039, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 478 participants
- Enrollment target
Study Summary
The Northwestern University Two-Generation Child and Family Outcomes Study (NU2Gen) of the Community Action Project of Tulsa County's (CAP Tulsa's) CareerAdvance® program examines the effects of CareerAdvance® on parent and child human capital outcomes (e.g., child academic achievement, parent educational advancement and certification, and psychological and family functioning), and (2) explore mechanisms that might give rise to program effects (e.g., home language environment; coping, balance, and stress; and parent and academic and career identity).
Primary Outcome
We expect higher rates of employment
Interventions
- BEHAVIORAL CareerAdvance®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 478 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-09 |
| Phase | NA |
What the finished NCT02743039 record still lists
NCT02743039 is an interventional study that assigns participants to a tested intervention. The registered 478 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 1 intervention - of which CareerAdvance® is the first listed.
NCT02743039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02743039 about?
NCT02743039 is a clinical study titled "The Northwestern University Two-Generation Study of Parent and Child Human Capital Advancement". The Northwestern University Two-Generation Child and Family Outcomes Study (NU2Gen) of the Community Action Project of Tulsa County's (CAP Tulsa's) CareerAdvance® program examines the effects of CareerAdvance® on parent and child human capital outcomes (e.g., child academic achievement, parent educa...
What is the current status of trial NCT02743039?
This trial is currently completed. It is a NA study. The enrollment target is 478 participants. The study started on 2016-04. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02743039?
The interventions under investigation include: CareerAdvance® (BEHAVIORAL).
Who is sponsoring clinical trial NCT02743039?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02743039's enrollment target sits among peer trials
478 218th of 2000 higher than 1,782 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05446272 · 478 participants · NA
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
- NCT06172296 · 478 participants · Phase 3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- NCT04221542 · 479 participants · Phase 1
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- NCT03911700 · 477 participants · NA
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia